Abstract Background Meta-analyses (MA) based on individual patient data (IPD) are regarded as the gold standard for meta-analyses and are becoming increasingly common, having several advantages over meta-analyses of summary statistics. These analyses are being undertaken in an increasing diversity of settings, often having a binary outcome. In a previous systematic review of articles published between 1999–2001, the statistical approach was seldom reported in sufficient detail, and the outcome was binary in 32% of the studies considered. Here, we explore statistical methods used for IPD-MA of binary outcomes only, a decade later. Methods ...
Randomized clinical trials provide the most reliable estimates of the benefits and harms of treatmen...
Contains fulltext : 110327pub.pdf (publisher's version ) (Closed access)- An IPD (...
Background: A fundamental aspect of epidemiological studies concerns the estimation of factor-outcom...
Background: Meta-analyses based on individual patient data (IPD) are regarded as the gold standard f...
Background: Meta-analyses based on individual patient data (IPD) are regarded as the gold standard f...
Randomized clinical trials provide the most reliable estimates of the benefits and harms of treatmen...
Randomized clinical trials provide the most reliable estimates of the benefits and harms of treatmen...
Randomized clinical trials provide the most reliable estimates of the benefits and harms of treatmen...
Case-mix heterogeneity across studies complicates meta-analyses. As a result of this, treatments tha...
Background: In meta-analyses of clinical trials, clinicians are often interested in examining subset...
Meta-analysis using individual participant data (IPD) obtains and synthesises the raw, participant-l...
OBJECTIVES: To determine whether individual patient data meta-analyses (IPDMA) are used to perform s...
Background: A fundamental aspect of epidemiological studies concerns the estimation of factor-outcom...
Meta-analysis that pools two levels of data, namely, aggregate data (AD) and individual patient data...
BACKGROUND: A fundamental aspect of epidemiological studies concerns the estimation of factor-outcom...
Randomized clinical trials provide the most reliable estimates of the benefits and harms of treatmen...
Contains fulltext : 110327pub.pdf (publisher's version ) (Closed access)- An IPD (...
Background: A fundamental aspect of epidemiological studies concerns the estimation of factor-outcom...
Background: Meta-analyses based on individual patient data (IPD) are regarded as the gold standard f...
Background: Meta-analyses based on individual patient data (IPD) are regarded as the gold standard f...
Randomized clinical trials provide the most reliable estimates of the benefits and harms of treatmen...
Randomized clinical trials provide the most reliable estimates of the benefits and harms of treatmen...
Randomized clinical trials provide the most reliable estimates of the benefits and harms of treatmen...
Case-mix heterogeneity across studies complicates meta-analyses. As a result of this, treatments tha...
Background: In meta-analyses of clinical trials, clinicians are often interested in examining subset...
Meta-analysis using individual participant data (IPD) obtains and synthesises the raw, participant-l...
OBJECTIVES: To determine whether individual patient data meta-analyses (IPDMA) are used to perform s...
Background: A fundamental aspect of epidemiological studies concerns the estimation of factor-outcom...
Meta-analysis that pools two levels of data, namely, aggregate data (AD) and individual patient data...
BACKGROUND: A fundamental aspect of epidemiological studies concerns the estimation of factor-outcom...
Randomized clinical trials provide the most reliable estimates of the benefits and harms of treatmen...
Contains fulltext : 110327pub.pdf (publisher's version ) (Closed access)- An IPD (...
Background: A fundamental aspect of epidemiological studies concerns the estimation of factor-outcom...